Results 151 to 160 of about 13,238 (197)
Some of the next articles are maybe not open access.
Current Treatment Options in Cardiovascular Medicine, 2001
The major goal in treatment of patients with dyslipidemia is to decrease the short- and long-term incidence of cardiovascular events, including myocardial infarction, unstable angina, stroke, and death. A second goal in patients with severe hypertriglyceridemia is to decrease the risk of acute pancreatitis.
Adam M., Cohen, Daniel J., Rader
openaire +2 more sources
The major goal in treatment of patients with dyslipidemia is to decrease the short- and long-term incidence of cardiovascular events, including myocardial infarction, unstable angina, stroke, and death. A second goal in patients with severe hypertriglyceridemia is to decrease the risk of acute pancreatitis.
Adam M., Cohen, Daniel J., Rader
openaire +2 more sources
Current Diabetes Reports, 2001
Numerous prospective cohort studies have indicated that diabetes mellitus (DM), particularly type-2 DM (the type of diabetes associated with insulin resistance that usually strikes adults), is associated with a 3-4-fold increase in risk for coronary heart disease (CHD) [1-3].
H N, Ginsberg, C, Tuck
openaire +3 more sources
Numerous prospective cohort studies have indicated that diabetes mellitus (DM), particularly type-2 DM (the type of diabetes associated with insulin resistance that usually strikes adults), is associated with a 3-4-fold increase in risk for coronary heart disease (CHD) [1-3].
H N, Ginsberg, C, Tuck
openaire +3 more sources
Endocrinology and Metabolism Clinics of North America, 2015
"Recent studies have revealed evidence that poorly controlled cholesterol, triglycerides, and their metabolites during pregnancy may be associated with cardiometabolic dysfunction and have significant detrimental fetal and maternal vascular consequences.
Robert, Wild +2 more
openaire +3 more sources
"Recent studies have revealed evidence that poorly controlled cholesterol, triglycerides, and their metabolites during pregnancy may be associated with cardiometabolic dysfunction and have significant detrimental fetal and maternal vascular consequences.
Robert, Wild +2 more
openaire +3 more sources
Endocrinology and Metabolism Clinics of North America, 2008
The alarming and still increasing prevalence of obesity and associated cardiovascular risk raises much concern. The increase in cardiovascular risk depends to a significant extent on the changes in lipid profiles as observed in obesity. These changes are decreased high-density lipoprotein cholesterol and increased triglyceride levels.
Franssen, Remco +3 more
openaire +3 more sources
The alarming and still increasing prevalence of obesity and associated cardiovascular risk raises much concern. The increase in cardiovascular risk depends to a significant extent on the changes in lipid profiles as observed in obesity. These changes are decreased high-density lipoprotein cholesterol and increased triglyceride levels.
Franssen, Remco +3 more
openaire +3 more sources
Endocrinology and Metabolism Clinics of North America, 2006
Type 2 diabetes mellitus is associated with a markedly increased risk of cardiovascular disease. A complex dyslipidemia, which is an integral part of the underlying insulin resistance in this group, is a key to this increased risk. Increased secretion of VLDL from the liver is a central feature of dyslipidemia and is linked significantly to the low HDL
Tina J, Chahil, Henry N, Ginsberg
openaire +2 more sources
Type 2 diabetes mellitus is associated with a markedly increased risk of cardiovascular disease. A complex dyslipidemia, which is an integral part of the underlying insulin resistance in this group, is a key to this increased risk. Increased secretion of VLDL from the liver is a central feature of dyslipidemia and is linked significantly to the low HDL
Tina J, Chahil, Henry N, Ginsberg
openaire +2 more sources
APOE genotypes and dyslipidemias in a sample of the Portuguese population [PDF]
Clinical Chemistry and Laboratory Medicine, 2005 The objective of this work was to study the distribution of apolipoprotein E (APOE) genotypes in a sample of the Portuguese population, and its association with the dyslipidemias observed.
Carlos Dias
exaly +2 more sources
Combined hormonal contraceptive use among women with known dyslipidemias: a systematic review of critical safety outcomes [PDF]
Contraception, 2016 ContextDyslipidemias represent a spectrum of lipid disorders that are important risk factors for cardiovascular disease. In addition, elevated triglycerides are known to be associated with pancreatitis.
Kathryn Curtis +2 more
exaly +2 more sources
Metabolism, 2019
Obesity, a pandemic of the modern world, is intimately associated with dyslipidemia, which is mainly driven by the effects of insulin resistance and pro-inflammatory adipokines. However, recent evidence suggests that obesity-induced dyslipidemia is not a unique pathophysiological entity, but rather has distinct characteristics depending on many ...
Vekić, Jelena +4 more
openaire +4 more sources
Obesity, a pandemic of the modern world, is intimately associated with dyslipidemia, which is mainly driven by the effects of insulin resistance and pro-inflammatory adipokines. However, recent evidence suggests that obesity-induced dyslipidemia is not a unique pathophysiological entity, but rather has distinct characteristics depending on many ...
Vekić, Jelena +4 more
openaire +4 more sources
Nursing Clinics of North America, 2023
Cardiovascular disease (CVD) is the leading cause of morbidity and mortality in the United States. The development and progression of atherosclerotic CVD are largely dependent on a multitude of modifiable and nonmodifiable risk factors. Current therapeutic strategies involve risk factor modification, especially dyslipidemia.
Jennifer, Ballard-Hernandez, James, Sall
openaire +2 more sources
Cardiovascular disease (CVD) is the leading cause of morbidity and mortality in the United States. The development and progression of atherosclerotic CVD are largely dependent on a multitude of modifiable and nonmodifiable risk factors. Current therapeutic strategies involve risk factor modification, especially dyslipidemia.
Jennifer, Ballard-Hernandez, James, Sall
openaire +2 more sources
Current Atherosclerosis Reports, 2023
This article sumarizes pathopysiological consequencies between obesity and dyslipidemia and aims to bring some practical approach.Dyslipidemia is often present in individuals with obesity and simultaneusly, many obese individuals have lipid metabolism disorders. Especially the abdominal obesity increases the cardiometabolic risk because of the presence
Barbora Nussbaumerova, Hana Rosolova
openaire +2 more sources
This article sumarizes pathopysiological consequencies between obesity and dyslipidemia and aims to bring some practical approach.Dyslipidemia is often present in individuals with obesity and simultaneusly, many obese individuals have lipid metabolism disorders. Especially the abdominal obesity increases the cardiometabolic risk because of the presence
Barbora Nussbaumerova, Hana Rosolova
openaire +2 more sources